will medicaid cover glp 1 drugs SC program to stop covering expensive weight loss for obesity • SC Daily Gazette GLP-1 Weight Loss Drugs: Coverage
Description
Zepbound is a dual GIP and GLP-1 receptor agonist, which means it activates both incretin pathways to enhance blood sugar control and support effective, long-term weight loss
The study made headlines at the 2026 American Society of Clinical Oncology (ASCO) annual meeting in June
With retatrutide, Eli Lilly aims to bring to market a "triple agonist," targeting GLP-1 and GIP receptors, as well as glucagon receptors
If you are on an employer-sponsored plan, check with your HR department about whether the employer purchased a GLP-1 rider to maintain coverage
Some people link their injection to a specific weekly routine, like Sunday evening after dinner or Monday morning before work
(2017) 25:107590.e5
